drug-eluting

Gregg Stone REFERENCE: Abstract 2357, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida GREGG STONE, Columbia University, New York New light has been thrown on the u

Joseph Muhlestein Sidney Smith Joost Daemen Drug Eluting Stents: More Deaths in Real World Use REFERENCE: American Heart Association Scientific Sessions, Chicago, November 12-15, 2006. Abstract: 2225

Oscar Marroquin Sanjay Kaul Joseph Sweeny Maximo Rivero-Ayerza Repeat Revascularization With Drug Eluting versus Bare Metal Stents REFERENCE: American Heart Association Scientific Sessions, Chicago, N

CHRISTIAN SPAULDING, Cochin Hospital, Paris REFERENCE: N Engl J Med 2006;355:1093, 1105,1169 Two leading articles in the same edition of the New England Journal of Medicine have investigated the use o

REFERENCE: Abstract 1011 to 1016 Tony Gershlick, Leicester University A session entitled: “Stent Thrombosis in the Drug-Eluting Stents Era” at the Barcelona congress identified important m

Matthias Pfisterer, University Hospital Basel American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 422-11. Lancet 2005:366:921 Clopidogrel therapy may

Drug-eluting stents should not be the favoured option for treating saphenous vein graft lesions according conclusions from a registry analysis presented to the American Heart Association conference by

Matthias Pfisterer Drug-eluting stents and their additional benefit to low-risk patients were investigated in a cost-effectiveness analysis presented to the Stockholm cardiology meeting by Matthias Pf